Advantages and controversies of depot antipsychotics in the treatment of patients with schizophrenia

Breit, Sigrid; Hasler, Gregor (2016). Advantages and controversies of depot antipsychotics in the treatment of patients with schizophrenia. Nervenarzt, 87(7), pp. 719-723. Springer-Medizin-Verlag 10.1007/s00115-015-0021-9

Preview	Text Breit_Hasler_2016_Depotantipsychotika.pdf - Published Version Available under License Publisher holds Copyright. Download (159kB) | Preview
Preview	Text Breit_Hasler_2015_Depotantipsychotika Schizophrenie.pdf - Accepted Version Available under License Publisher holds Copyright. Download (129kB) | Preview

BACKGROUND

The objective of this article is to give an overview of the advantages and disadvantages of the use of depot antipsychotics in the treatment of schizophrenia. The focus is on efficacy, tolerability, relapse prevention, patient compliance and satisfaction compared to oral administration forms.

MATERIAL AND METHODS

A literature search was conducted in medical databases. The results of meta-analyses, randomized controlled trials and systematic reviews from the years 1999-2014 were included.

RESULTS AND DISCUSSION

Depot antipsychotics ensure maintenance of constant blood levels and a continuous medication delivery. The efficacy and tolerability of depot antipsychotics are comparable to oral administration forms. Due to an improved medication compliance a reduction of relapse and hospitalization rates can be achieved. This is a key focus for improving outcomes and reducing costs in the treatment of schizophrenia.

Interest & Impact

Downloads

831 since deposited on 07 Jan 2016
224 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item